Observational studyMedicine2026
Temporal trends of atrial fibrillation and atrial flutter burden across the BRICS: An observational study analysis for the GBD 2021.
Observational study in Medicine, 2026. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Not yet cited in PubMed.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
0 citing papers in PubMed.
No citing paper in PubMed yet.
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
3 authors.
Funding
Abstract
Atrial fibrillation (AF) and atrial flutter (AFL) are major and rising causes of cardiovascular morbidity, but comparable long-term evidence across Brazil, Russia, India, China, South Africa (BRICS) is limited. We conducted a population level, retrospective ecological time-trend analysis using aggregated Global Burden of Disease 2021 estimates (1992-2021). We analyzed incident cases and age-standardized incidence rates (ASIRs). Age-period-cohort models quantified age, period, and cohort effects; decomposition assessed drivers of case growth; and autoregressive integrated moving average projected ASIRs for 2022 to 2036. Incident cases increased in all BRICS countries, with the highest 2021 counts in China (9,16,180) and India (5,70,120). ASIR trends differed: Brazil declined to 2019 with a recent uptick; China was relatively stable (44.9 per 1,00,000 in 2021); Russia peaked in the early 2010s then declined; India rose slightly; and South Africa declined modestly. Population growth was a major driver (India 74.71%; China 55.69%; South Africa 96.96%). By 2036, ASIRs are projected to remain high in Brazil (67.63), increase in Russia (57.22), and decline then stabilize in China (42.47); India will slightly decrease (50.07) and South Africa will remain stable (48.66). The findings highlight demographic forces as key determinants of AF/AFL burden and imply the need for tailored screening, prevention, and surveillance to guide allocation of cardiovascular care resources across BRICS.
Indexed as
Identifiers
What Socratic holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the Socratic graph.